TP53 and neoplasm: Deep sequencing revealed that U-CH22 harbours critical mutations in the TP53 gene, a possible splice site disruptive mutation (c.69+1G>C) and a mutation causing a premature stop codon (c.538G>T), potentially fostering the tumour’s aggressiveness and proliferation speed.